Q301-- Molecular Thyroid Testing

Sources Sought Notice Molecular Thyroid Testing

Disclaimer:

This Request for Information (RFI) is issued solely for market research information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are NOT offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI.

Information Requested from Industry:

In response to the Sources Sought, interested Contractors shall submit the following information and any Capabilities/Qualifications Statement to include but not limited to an overview of proposed solution(s) and a description of the product your company possesses in accordance with the Statement of Work draft / Salient Characteristics List.

Responses to market research table questionnaire shall be submitted. If this information is not provided, then it will be assumed the entire requirement cannot be met.

Description of Requirement:

The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office 19 (NCO 19) is conducting a market survey and is seeking potential sources for Molecular Thyroid Testing at the Rocky Mountain Regional VA Medical Center. This Sources Sought Notice is issued for information and planning purposes only. This is not a solicitation or a request for proposal and shall not be construed as an obligation or commitment by the Government. An award will not be made on any offers submitted in response to this notice, and it shall not be implied the Government is committed to providing any solicitation or award following this notice. The Government will not pay for any information received in response to this request, nor will the Government compensate a respondent for any costs incurred in developing the information provided.

Requirement Item OR Services:

Item No.

Service

Item Description

1

Thyroid Testing

Molecular Thyroid Mutation Testing

Projected Period of Performance:

09-25-2026 09 24-2031

SOW Requirements:

Must be able to test for mutation thyroid samples, Fine Needle Aspiration (FNA), Cytology slide smears, FNA Cell Block, Resected Tissue (tumors), and any other acceptable sample types.

Must supply each Government facility with its commercial laboratory reference test manual to ensure that the collection and storage of specimens.

Must supply each Government facility with its commercial laboratory reference test manual to ensure that the collection and storage of specimens.

Must provide all necessary shipping supplies, including compliant packaging, temperature-controlled containers, labels, and test requisition forms, in accordance with 42 CFR Part 72, 49 CFR Parts 171 and 173, and IATA Dangerous Goods Regulations.

Must perform molecular testing on tissue obtained through fine needle aspiration, including genomic sequencing to evaluate mRNA expression profiles and classify results as benign or suspicious for malignancy, and provide BRAF and RET/PTC mutation testing to assist with surgical decision-making.

Testing must be performed Monday through Saturday, with results reported within 14 days of specimen receipt.

In response to this announcement, please provide the information requested below requested in this market research table questionnaire. If this information is not provided, then it will be assumed the entire requirement cannot be met:

NAICS Code: 621511

Company Name:

Address:

UEI (Unique Entity ID) Number:

Contact Name:

Phone No.:

Email:

Business Size Information - Select all that applies:

Small Business

Emerging Small Business

Small Disadvantaged Business

Certified under Section 8(a) of the Small Business Act

HUBZone

Woman Owned

Certified Service-Disabled Veteran Owned Small

Veteran Owned Small Business

Large Business

FSS/GSA Contract Holder:

Yes No

FSS/GSA Contract Number:

Effective Date/ Expiration Date:

Proposed solution is listed and available on the above FSS/GSA Contract:

Yes No

Available pricing structure of proposed solution:

Pricing Model

Please Indicate Availability Below: (Yes / No / NA)

All on FSS

Open Market only

Mix of FSS & Open Market

(CPRR) Cost Per Reportable Result

Cost Per Test(CPT)

Fixed Monthly Charge

Firm-Fixed Price

Other: (Please explain)

Federal Acquisition Regulation (FAR) Market Rearch Questions:

Buy American Act RFO 52.225-1 and RFO 52.225-2 Buy American Certificate What percentage of the proposed product (including leases and rentals) is a:

Domestic end product? _____________ (%)

Foreign end product? _______________ (%) Country of Origin:

Questions for Small Businesses ONLY:

Limitations on Subcontracting RFO 52.219-14

What percentage of the work would be subcontracted to another company? ________

What is the business size of the subcontractor?______

Per RFO 52.219-14 the following conditions must be met:

Services (except construction), it will not pay more than 50 percent of the amount paid by the Government for contract performance to subcontractors that are not similarly situated entities. Any work that a similarly situated entity further subcontracts will count towards the prime contractor's 50 percent subcontract amount that cannot be exceeded. When a contract includes both services and supplies, the 50 percent limitation shall apply only to the service portion of the contract;

Supplies (other than procurement from a nonmanufacturer of such supplies), it will not pay more than 50 percent of the amount paid by the Government for contract performance, excluding the cost of materials, to subcontractors that are not similarly situated entities. Any work that a similarly situated entity further subcontracts will count towards the prime contractor's 50 percent subcontract amount that cannot be exceeded. When a contract includes both supplies and services, the 50 percent limitation shall apply only to the supply portion of the contract;

If subcontracting, what added value do you offer (RFO 52.215-23):

Nonmanufacturer Rule (RFO 52.219-33):

Does your company manufacturer these proposed items? [Â ] yes [Â ] no

Does your company exceed 500 employees? [Â ] yes [Â ] no If yes, list # of employees: _________

Does your company primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied? [Â ] yes [Â ] no

Does your company take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? [Â ] yes [Â ] no

Does your company supply the end item of a small business manufacturer, processor or producer made in the United States, or obtains a waiver of such requirement pursuant to paragraph (b)(5) CFR 121.406. [Â ] yes [Â ] no If yes, what is the manufacturer s name? ________________

Response Instructions:

Submit your response via email to Kadarius.Griffin@va.gov

Submit your response NLT 10:00 (CST) on Wednesday, April 1st, 2026.

Mark your response as Proprietary Information if the information is considered business sensitive.

VA has identified the appropriate North American Industry Classification System (NAICS) Code as 621511 Medical Laboratories with a Small Business size of $41.5 Million. Please identify and explain any NAICS codes your company believes would better represent the predominant work included in the attached Statement of Work draft.

(End of Sources Sought)